Wells Fargo & Company Neuro Pace Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Neuro Pace Inc stock. As of the latest transaction made, Wells Fargo & Company holds 4,204 shares of NPCE stock, worth $45,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,204

Previous 6,370 34.0%

Holding current value

$45,613

Previous $48,000 39.58%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.65 - $8.46 $14,403 - $18,324	-2,166 Reduced 34.0%	4,204 $29,000
Q2 2024 Aug 13, 2024	BUY	$6.38 - $15.33 $27,357 - $65,735	4,288 Added 205.96%	6,370 $48,000
Q1 2024 May 10, 2024	BUY	$9.78 - $17.5 $19,569 - $35,017	2,001 Added 2470.37%	2,082 $27,000
Q4 2023 Feb 09, 2024	BUY	$5.9 - $10.31 $41 - $72	7 Added 9.46%	81 $0
Q3 2023 Nov 13, 2023	SELL	$4.0 - $9.73 $596 - $1,449	-149 Reduced 66.82%	74 $0
Q2 2023 Aug 15, 2023	BUY	$3.98 - $5.12 $15 - $20	4 Added 1.83%	223 $1,000
Q1 2023 May 12, 2023	BUY	$1.44 - $5.34 $217 - $806	151 Added 222.06%	219 $1,000
Q4 2022 Feb 13, 2023	SELL	$1.29 - $3.67 $23 - $66	-18 Reduced 20.93%	68 $0
Q3 2022 Nov 14, 2022	BUY	$3.1 - $5.98 $133 - $257	43 Added 100.0%	86 $0
Q2 2022 Aug 12, 2022	SELL	$4.95 - $8.7 $7,687 - $13,511	-1,553 Reduced 97.31%	43 $0
Q1 2022 May 16, 2022	SELL	$7.06 - $11.57 $17,473 - $28,635	-2,475 Reduced 60.8%	1,596 $13,000
Q4 2021 Feb 14, 2022	SELL	$8.63 - $17.36 $52,712 - $106,034	-6,108 Reduced 60.01%	4,071 $41,000
Q3 2021 Nov 15, 2021	SELL	$15.85 - $25.07 $665 - $1,052	-42 Reduced 0.41%	10,179 $161,000
Q2 2021 Aug 16, 2021	BUY	$19.03 - $26.5 $194,505 - $270,856	10,221 New	10,221 $243,000

Others Institutions Holding NPCE

# of Institutions

Shares Held

21.3M

Call Options Held

1.3K

Put Options Held

100

View Full List

About NeuroPace Inc

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $270M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

More about NPCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Neuro Pace Inc Transaction History